We are live on ! Find out more
BL

Bleichroeder LP Portfolio holdings

AUM $559M Turnover 17.24%
1-Year Est. Return 83.7%
This Fund
S&P 500
This Quarter Est. Return
+5.53%
1 Year Est. Return
+83.7%
3 Year Est. Return
+202.15%
5 Year Est. Return
+208.71%
10 Year Est. Return
–
AUM
$559M
AUM Growth
-$6.54M
Cap. Flow
-$4.83M
Cap. Flow %
-0.87%
Top 10 Hldgs %
65.7%
Holding
77
New
3
Increased
6
Reduced
4
Closed
2
Avg Time Held
0.5 years
Top 10 Avg Time Held
0.6 years
Top 20 Avg Time Held
0.6 years

Top Buys

Rank Stock Value
1
FGNA.U
FG New America Acquisition Corp. Units, each consisting of one share of Class A common stock and one
FGNA.U
+$5M
2
ADVM icon
Adverum Biotechnologies
ADVM
+$2.25M
3
TGTX icon
TG Therapeutics
TGTX
+$1.61M
4
MRNS icon
Marinus Pharmaceuticals, Inc
MRNS
+$1.02M
5
FATE icon
Fate Therapeutics
FATE
+$697K

Top Sells

Rank Stock Value
1
ARKO icon
ARKO Corp
ARKO
+$10.3M
2
BLFS icon
BioLife Solutions
BLFS
+$3.46M
3
FLNA icon
Filana Therapeutics
FLNA
+$1.65M
4
DRRX icon
DURECT Corp
DRRX
+$501K
5
CUE icon
Cue Biopharma
CUE
+$288K

Sector Composition

Rank Sector Weight
1 Healthcare 26.25%
2 Industrials 17.34%
3 Miscellaneous 16.1%
4 Energy 10.35%
5 Materials 8.21%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow Held Since
NS icon
26
DELISTED
NuStar Energy L.P.
NS
$4.63M 0.83%
435,500
– –
2019 Q4
3 quarters
BX icon
27
Blackstone
BX
$87.1B
$4.18M 0.75%
80,000
– –
2019 Q4
3 quarters
FATE icon
28
Fate Therapeutics
FATE
$231M
$4M 0.72%
100,000
+19,972
+25% +$697K
2020 Q2
1 quarter
LSXMA icon
29
DELISTED
Liberty Media Corporation Series A Liberty SiriusXM Common Stock
LSXMA
$3.44M 0.61%
141,002
– –
2020 Q2
1 quarter
JPM icon
30
JPMorgan Chase
JPM
$891B
$2.89M 0.52%
30,000
– –
2019 Q4
3 quarters
AXP icon
31
American Express
AXP
$212B
$2.51M 0.45%
25,000
– –
2019 Q4
3 quarters
AMP icon
32
Ameriprise Financial
AMP
$44.4B
$2.46M 0.44%
15,993
– –
2019 Q4
3 quarters
DNTH icon
33
Dianthus Therapeutics
DNTH
$4.17B
$2.39M 0.43%
21,992
– –
2020 Q1
2 quarters
OIG
34
DELISTED
Orbital Infrastructure Group, Inc. Common Stock
OIG
$2.29M 0.41%
92,514
– –
2019 Q4
3 quarters
CUE icon
35
Cue Biopharma
CUE
$136M
$2.26M 0.4%
5,000
-500
-9% -$288K
2019 Q4
3 quarters
DISH
36
DELISTED
DISH Network Corp.
DISH
$2.25M 0.4%
77,500
– –
2020 Q1
2 quarters
IHC
37
DELISTED
Independence Holding Company
IHC
$2.06M 0.37%
54,711
– –
2019 Q4
3 quarters
EPD icon
38
Enterprise Products Partners
EPD
$76.8B
$1.99M 0.36%
126,301
– –
2019 Q4
3 quarters
TGTX icon
39
TG Therapeutics
TGTX
$8.57B
$1.87M 0.34%
+70,000
New +$1.61M
2020 Q3
0 quarters
DUOT icon
40
Duos Technologies
DUOT
$181M
$1.73M 0.31%
453,616
– –
2020 Q1
2 quarters
ADVM icon
41
DELISTED
Adverum Biotechnologies
ADVM
$1.54M 0.28%
+15,000
New +$2.25M
2020 Q3
0 quarters
LBTYK icon
42
Liberty Global Class C
LBTYK
$2.69B
$1.43M 0.26%
69,618
– –
2019 Q4
3 quarters
BLUE icon
43
DELISTED
bluebird bio
BLUE
$1.35M 0.24%
1,930
– –
2020 Q2
1 quarter
ORTX
44
DELISTED
Orchard Therapeutics plc American Depositary Shares
ORTX
$1.03M 0.18%
25,000
+12,480
+100% +$645K
2020 Q1
2 quarters
PYPL icon
45
PayPal
PYPL
$48.9B
$985K 0.18%
5,000
– –
2020 Q1
2 quarters
RIBT
46
DELISTED
RiceBran Technologies
RIBT
$715K 0.13%
170,333
– –
2019 Q4
3 quarters
LBTYA icon
47
Liberty Global Class A
LBTYA
$2.74B
$483K 0.09%
22,989
– –
2019 Q4
3 quarters
GRTS icon
48
DELISTED
Gritstone bio, Inc. Common Stock
GRTS
$448K 0.08%
169,039
– –
2020 Q1
2 quarters
BATRK icon
49
Atlanta Braves Holdings Series B
BATRK
$3.17B
$435K 0.08%
20,717
– –
2020 Q2
1 quarter
RTX icon
50
RTX Corp
RTX
$252B
$345K 0.06%
6,000
– –
2020 Q2
1 quarter
1
2
3 4

Similar funds

NFW
Noble Family Wealth Clearwater, Florida $559M AUM 24.35% 1-Year Est. Return
SCM
Soros Capital Management New York $559M AUM 171.77% 1-Year Est. Return
PHC
Palidye Holdings (Caymans) Grand Cayman, Cayman Islands $559M AUM 1.08% 1-Year Est. Return
EPM
Equitec Proprietary Markets Chicago, Illinois $559M AUM 230.29% 1-Year Est. Return
BCM
Brasada Capital Management Houston, Texas $558M AUM 21.68% 1-Year Est. Return
FAM
Frontier Asset Management Sheridan, Wyoming $558M AUM 22.41% 1-Year Est. Return
WDG
Wealth Dimensions Group Cincinnati, Ohio $558M AUM 20.63% 1-Year Est. Return
OC
Opal Capital Boca Raton, Florida $560M AUM

Bleichroeder LP's Q3 2020 Portfolio in Review

As of Q3 2020, Bleichroeder LP held 77 positions worth $559M, down 1.2% from $565M the previous quarter. Its ten largest holdings account for 66% of the portfolio.

Bleichroeder LP's Q3 2020 filing shows 3 new, 6 increased, 4 reduced and 2 closed positions. Its largest new stake was FG New America Acquisition Corp. Units, each consisting of one share of Class A common stock and one: 500,000 shares worth $5M. The largest sale was ARKO Corp, an estimated $10.3M.

By sector, the portfolio is most concentrated in Healthcare at 26% of assets, down from 29% a quarter earlier, followed by Industrials and Miscellaneous.

  • Bleichroeder LP's largest Q3 2020 buy was FG New America Acquisition Corp. Units, each consisting of one share of Class A common stock and one: 500,000 shares worth $5M.
  • Bleichroeder LP added most to Marinus Pharmaceuticals, Inc in Q3 2020, an estimated $1.02M increase.
  • Bleichroeder LP's biggest Q3 2020 reduction was Filana Therapeutics, cutting an estimated $1.65M.
  • Bleichroeder LP fully exited ARKO Corp in Q3 2020, selling an estimated $10.3M.
  • Bleichroeder LP's ten largest holdings make up 66% of its $559M portfolio in Q3 2020.
  • Bleichroeder LP opened 3 new positions and closed 2 in Q3 2020.
  • Bleichroeder LP's portfolio value fell 1.2% quarter-over-quarter to $559M.

Based on Bleichroeder LP's 13F filing for Q3 2020, filed 12 Nov 2020.